Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-5849
Authors: Staubitz, Julia Isabelle
Hoppe-Lotichius, Maria
Baumgart, J.
Mittler, J.
Lang, H.
Musholt, Thomas Johannes
Title: Survival after adrenalectomy for metastatic hepatocellular carcinoma : a 25-year institutional experience
Online publication date: 7-May-2021
Language: english
Abstract: BACKGROUND Extrahepatic manifestation of hepatocellular carcinoma (HCC) is rare and primarily affects lung, lymph nodes and bone. Metastases to the adrenal glands are relatively infrequent. This 25-year institutional experience aimed for an analysis of factors influencing survival in patients undergoing surgery for HCC adrenal metastasis. METHODS A retrospective analysis of the institutional database of the Clinic for General-, Visceral- and Transplantation Surgery of the University Medical Center Mainz, Germany, was performed. Patients who underwent surgery for HCC adrenal metastases from January 1995 to June 2020 were included. Pre-, peri- and postoperative factors with potential influence on survival were assessed. RESULTS In 16 patients (14 males, two females), one bilateral and 15 unilateral adrenalectomies were performed (13 metachronous, three synchronous). Thirteen operations were carried out via laparotomy, and three adrenalectomies were minimally invasive (two laparoscopic, one retroperitoneoscopic). Median overall survival (after HCC diagnosis) was 35 months, range: 5–198. Median post-resection survival (after adrenalectomy) was 15 months, range: 0–75. Overall survival was longer in patients with the primary HCC treatment being liver transplantation (median 66 months) or liver resection (median 51 months), compared to only palliative intended treatment of the primary with chemotherapy (median 35 months) or local ablation (median 23 months). CONCLUSIONS Surgery is a feasible treatment option for patients with adrenal metastases originating from HCC. In patients who underwent adrenalectomy for HCC adrenal metastasis, overall survival was superior, if primary HCC treatment was potentially curative (liver transplantation or resection).
DDC: 610 Medizin
610 Medical sciences
Institution: Johannes Gutenberg-Universität Mainz
Department: FB 04 Medizin
Place: Mainz
DOI: http://doi.org/10.25358/openscience-5849
Version: Published version
Publication type: Zeitschriftenaufsatz
License: CC BY
Information on rights of use: https://creativecommons.org/licenses/by/4.0/
Journal: World journal of surgery
45
Pages or article number: 1118
1125
Publisher: Springer
Publisher place: New York, NY
Issue date: 2021
ISSN: 1432-2323
Publisher URL: https://doi.org/10.1007/s00268-020-05909-0
Publisher DOI: 10.1007/s00268-020-05909-0
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
staubitz_j._i.-survival_after-20210427124443631.pdf445.25 kBAdobe PDFView/Open